DAPTOMYCIN (LY146032) TREATMENT OF EXPERIMENTAL ENTEROCOCCAL ENDOCARDITIS

被引：45

作者：

BUSH, LM ^{[1
]}

BOSCIA, JA ^{[1
]}

KAYE, D ^{[1
]}

机构：

[1] MED COLL PENN,DEPT MED,DIV INFECT DIS,3300 HENRY AVE,PHILADELPHIA,PA 19129

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1988年 / 32卷 / 06期

关键词：

D O I：

10.1128/AAC.32.6.877

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

引用

页码：877 / 881

页数：5

共 23 条

[1]

ANHALT JP, 1985, MANUAL CLIN MICROBIO, P1009

[2]

CARRIZOSA J, 1976, J LAB CLIN MED, V88, P132

[3] CHEMOTHERAPY OF EXPERIMENTAL STREPTOCOCCAL ENDOCARDITIS .1. COMPARISON OF COMMONLY RECOMMENDED PROPHYLACTIC REGIMENS [J].

DURACK, DT ;

PETERSDORF, RG .

JOURNAL OF CLINICAL INVESTIGATION, 1973, 52 (03) :592-598

[4] INVITRO AND INVIVO ACTIVITY OF LY 146032, A NEW CYCLIC LIPOPEPTIDE ANTIBIOTIC [J].

ELIOPOULOS, GM ;

WILLEY, S ;

REISZNER, E ;

SPITZER, PG ;

CAPUTO, G ;

MOELLERING, RC .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 30 (04) :532-535

[5] INVITRO ACTIVITY OF LY146032 AGAINST STAPHYLOCOCCI, STREPTOCOCCI, AND ENTEROCOCCI [J].

FASS, RJ ;

HELSEL, VL .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 30 (05) :781-784

[6]

Jones R., 1985, MANUAL CLIN MICROBIO, P972

[7] ANTIMICROBIAL ACTIVITY AND SPECTRUM OF LY146032, A LIPOPEPTIDE ANTIBIOTIC, INCLUDING SUSCEPTIBILITY TESTING RECOMMENDATIONS [J].

JONES, RN ;

BARRY, AL .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (04) :625-629

[8]

Kaye D, 1976, INFECTIVE ENDOCARDIT, P43

[9]

KAYE D, 1981, TREATMENT INFECTIVE, P97

[10]

LEVISON ME, 1973, J INFECTIOUS DISEA S, V128, P354

← 1 2 3 →